Case 2
A 43 year old negress complained of discomfort around the lateral aspect of her left wrist. There was no clinical evidence of tenosynovitis, and radiographs showed degenerative changes around the scaphoid articulations. The area was infiltrated with 25 mg hydrocortisone (Hydrocortistab), which completely relieved her symptoms. Within 48 hours, however, an area of almost complete depigmentation measuring about 20 X 15 mm appeared over the anatomical snuff box. There was no subcutaneous atrophy and the degree of depigmentation remained unchanged over the following six months.
Area of almost complete skin depigmentation six months after the injection.
Comment
The side effects associated with the long term administration of corticosteroids are well known but relatively few complications have been reported after a single injection. Infection is probably the most important, but subcutaneous atrophy may occur, resulting in localised skin depression.'-" It has therefore been suggested that intralesional doses are not placed too superficially.1 2 Depigmentation is an unusual and distressing side effect of this form of treatment, and the Committee on Safety of Medicines is aware of only one further case. This occurred in an African woman who received one injection of methylprednisolone for tennis elbow. At the time of the report (three months after the onset of the depigmentation) there were no signs of recovery.
The cause of the depigmentation is not clear, but it may be related to either the steroid or to one of the supposedly biologically inactive constituents of the vehicle. Peview of published reports has shown no reports of depigmentation due to any of these compounds, so the depigmentation was probably caused by the steroids themselves. Several hypotheses have been advanced to explain the dermatological side effects of steroid therapy, including the mechanical effects of oedema,2 a direct cytotoxic effect,4 changes in ground substance,2 and vasoconstriction. Value of routine chest radiography in an acute geriatric unit Chest radiography is a recognised screening procedure for newly admitted patients aged over 60. We decided to assess how widespread and useful is this policy.
Methods and results
A questionnaire was sent to 97 departments of geriatric medicine to determine prevailing policy. Also 200 consecutive admissions to Northwick Park Hospital were assessed prospectively during a three month winter period. The diagnoses and proposed treatments were determined from history and clinical examination. A single frontal chest x ray film was then obtained and its effect on the clinical diagnosis and treatment documented.
The mean ages of the 131 female and 69 male patients were 82 and 80 years respectively. In 140 instances this was their first admission to the unit. Questionnaires were returned by 85 consultants and indicated that two thirds of hospitals obtained a routine film for all patients on admission. The table shows the results of the clinical survey. Fractionally under half of the chest films were abnormal. The management value of the films was placed into one of two categories: in category 1 (38 patients) the results of radiography affected management in either a positive manner-for example, when a bronchial carcinoma was detected-or negative manner-for example, no evidence of a bronchial carcinoma when this had been a possible diagnosis. Nineteen of the 38 patients had presented with cardiorespiratory symptoms. There were nine patients with toxic confusional states in whom radiography was useful by making it likely or unlikely that the respiratory or cardiovascular system was the underlying cause. In five patients admitted with bone pain the chest films influenced management-for example, by assessing secondary deposits in ribs or by making it likely or unlikely that a rib fracture was present.
In category 2 (162 patients) the chest film was either normal (102) or abnormal (60) but did not affect management. These patients included five with cardiorespiratory symptoms in whom radiography did not 
